Cigna Group (NYSE:CI) Stock Gets Price Target Trim from Guggenheim

Key Points

• Guggenheim lowered its Cigna price target from $361 to $347 but maintained a Buy rating; the revised target implies about 15% upside from the stock’s current price.
• Cigna beat quarterly estimates, reporting adjusted EPS of $7.98 versus $7.52 expected and revenue of $73.79 billion versus $72.64 billion; revenue rose 5.6% year over year.
• Analyst sentiment remains positive overall: 14 analysts rate the stock Buy and eight Hold, giving Cigna a consensus Moderate Buy rating and an average price target of $335.70.

Cigna Group (NYSE:CI - Get Free Report) had its price objective dropped by equities research analysts at Guggenheim from $361.00 to $347.00 in a research note issued on Friday, Benzinga reports. The firm presently has a "buy" rating on the health services provider's stock. Guggenheim's price target would indicate a potential upside of 15.03% from the stock's current price.

A number of other equities research analysts have also commented on the company. Piper Sandler reiterated an "overweight" rating on shares of Cigna Group in a research report on Friday, October 23rd. Robert W. Baird set a $362.00 price target on shares of Cigna Group in a report on Friday, July 31st. Barclays raised their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. UBS Group restated a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $340.00 price objective on shares of Cigna Group in a report on Friday. Fourteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $335.70.

Cigna Group Stock Performance

Shares of CI opened at $301.67 on Friday. The stock has a 50-day moving average of $285.48 and a two-hundred day moving average of $282.05. Cigna Group has a one year low of $255.53 and a one year high of $318.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market cap of $79.71 billion, a P/E ratio of 12.48, a P/E/G ratio of 1.03 and a beta of 0.25.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating the consensus estimate of $7.52 by $0.46. The business had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The company's quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.83 EPS. As a group, research analysts predict that Cigna Group will post 30.49 EPS for the current year.

Insider Activity

In other news, insider Everett Neville sold 617 shares of the company's stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the firm's stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On Cigna Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. increased its holdings in Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the last quarter. GQG Partners LLC purchased a new position in shares of Cigna Group during the second quarter worth $1,628,918,000. Bank of America Corp DE boosted its position in shares of Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider's stock worth $848,821,000 after buying an additional 256,677 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Cigna Group by 10.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider's stock valued at $647,008,000 after buying an additional 236,340 shares in the last quarter. Finally, Legal & General Group Plc purchased a new stake in shares of Cigna Group in the 2nd quarter valued at $542,779,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q3 adjusted EPS was $7.98, ahead of analyst estimates, and revenue rose about 6% year over year to $73.79 billion, also exceeding consensus. Cigna cited strength in its healthcare businesses and a favorable drug mix. Read More.
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share, reinforcing the view that operating performance is improving. Read More.
• Positive Sentiment: Cigna also outlined longer-term targets, including 10%–14% adjusted EPS growth and roughly $50 billion in cumulative operating cash flow through 2030. Its $3 billion “Accelerate to One” initiative is intended to improve productivity and modernize operations. Read More.
• Neutral Sentiment: The planned ACA market exit may simplify Cigna’s business focus, but it also marks a change in its health-insurance footprint. The impact will depend on how the company manages the transition. Read More.
• Negative Sentiment: GAAP net income was $1.44 billion, down from $1.87 billion a year earlier, and reported EPS declined to $5.47 from $6.98. That contrasts with the stronger adjusted results and may temper the headline earnings beat. Read More.

About Cigna Group

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.